Pertussis is increasingly being recognized as an important cause of cough illness in
adolescents and adults. To evaluate the safety and immunogenicity of an adult formulation …

A single blinded randomized controlled trial to compare the reactogenicity and
immunogenicity of adult formulated dTpa and monovalent pa vaccines with a licensed Td …

A tricomponent acellular pertussis vaccine containing pertussis toxoid, filamentous
hemagglutinin, and pertactin combined with diphtheria and tetanus toxoids (DTPa) was …

Pertussis is a highly contagious disease caused by Bordetella pertussis, spread by
respiratory droplets [1, 2]. B. pertussis is a strict human pathogen with no other known …

After 2 decades of development, acellular pertussis vaccines are becoming more widely
available for use. Products that contain from 1 to 5 purified antigens of Bordetella pertussis …

PURPOSE: This study was conducted to assess the immunogenicity and safety of a tetanus
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …

Availability of combined tetanus-diphtheria-acellular pertussis (Tdap) vaccines for adults
offers a new pertussis prevention strategy for the US. Successful uptake of Tdap vaccine will …

Reduced-antigen-content diphtheria–tetanus–acellular-pertussis (dTpa) vaccines are
predominantly recommended for once-in-a-lifetime use. A second dTpa (Boostrix™ …

An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with
acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in …

A trial to compare the reactogenicity and immunogenicity of a reduced antigen content
diphtheria–tetanus–acellular pertussis (dTpa) vaccine with diphtheria–tetanus–whole-cell …